
Call on : 612-850-5029
Mon to Sat 9:00AM to 9:00PM
Mail us : patriggs@tokimusbiotech.com
Introduction: The global COVID-19 pandemic and seasonal influenza outbreaks have drawn attention to the critical need for accurate and efficient diagnostic tools. Methods: The performance of the InstaView COVID-19/Flu Ag Combo Test, which was designed to simultaneously detect the SARS-CoV-2, influenza A, and influenza B viruses, was analytically and clinically evaluated.
years of experience
Tokimus Biotech was initially formed in 2020, to bring affordable, accessible, high-quality disease testing to North America. With the arrival of COVID-19, we dedicated ourselves to importing Covid19 antibody test kits and other emergency preparedness equipment and supplies to help governments and communities manage the virus.
Our suppliers had come were from all parts of the world, and we worked to develop certifications by the key regulatory bodies in where we operate.
The products we import are FDA approved under Section 564(c) of the Emergency Use Authorization (EUA) pursuant to Section 564 of the Federal Food, Drug and Cosmetic Act. They have also been approved European Regulatory Bodies with a CE mark and documentation of Conformance to all ISO standards and are tested by the National Institute of Health (NIH) and legally approved for sale in the United States.
We collaborate with internationally recognized, ISO-certified, and FDA-cleared manufacturers to bring cutting-edge biotech and medical equipment to North America.
Every product meets strict North American regulatory and performance requirements.
Our dual expertise in biotechnology and global logistics ensures efficient, compliant, and transparent delivery no matter the scale.
We work with public health organizations, Indigenous communities, clinics, and nonprofit partners to ensure essential healthcare technology reaches the areas that need it most.
Technology matters but impact matters more. Everything we deliver is aligned with improving health outcomes.
Tokimus Biotech provides comprehensive medical technology solutions, supporting healthcare providers, governments, clinics, and distributors as biomedical developers seeking to builda trusted portfolio of diagnostics, devices, and biotech innovations.
FDA/EUA, CE, ISO-certified partners
Trusted suppliers from South Korea, Europe, and emerging biotech hubs
Fair pricing models for clinics, government agencies, and community programs
Capable of supporting both high-volume procurement and specialized orders
Strong commitment to underserved regions and Indigenous health networks
Our services are trusted and reliable in all community.
Pat was born in Italy and has worked in the import/export business dealing with energy, food and restaurant products, oil field equipment and supplies since 2004. His primary business has been as a finance consultant and strategy advisor to middle market companies in re-capitalization for growth programs. He likewise provides guidance for early stage and small public companies seeking growth capital. As Import Manager for an international trading company, he developed long term relationships with several key Asian trading partners; an experience which is serving Tokimus Biotech very well as it established its relationships with Asian suppliers. Pat attended University of North Dakota in 1990 and completed study program receiving university credits at Harvard Business School in 2019.
Jason was born and raised in Taiwan and received his degree in accounting form Aletheia University in Taiwan. He completed his MBA at the University of Houston and is a licensed CPA in the United States. Due to his continued ties to Taiwan, China and Asia, Jason provides valuable insights into the business culture of Southeast Asia as well as providing valuable contacts there. In his career, he has been instrumental in financing both US and foreign entrepreneurial companies. Aside from managing the financial matters of Tokimus Biotech, Jason makes valuable business contacts for the company in Asia.